Tag: Clinical Trials

Huntsman Cancer Institute study exemplifies bench to bedsideCredit: Huntsman Cancer Institute SALT LAKE CITY - Researchers at Huntsman Cancer Institute ...

Sickle cell drug showing promise in clinical trial

Clinical trial data presented by UConn School of Medicine researchers at the 24th Congress of the European Hematology AssociationCredit: Photo ...

Human-on-a-chip model tests cancer drug efficacy and toxicity for therapeutic index

In vitro multi-organ system by Hesperos, Inc. realistically replicates the responses of cancer treatments and has potential to inform treatment ...

A miniature robot that could check colons for early signs of disease

Engineers have shown it is technically possible to guide a tiny robotic capsule inside the colon to take micro-ultrasound images. ...

Simple scan could direct treatments for angina

A 40 minute test for angina could help patients avoid an overnight stay in hospital, according to research funded by ...

ESMO World Congress on Gastrointestinal Cancer

Around 3,500 oncology professionals and researchers from around the world will learn about the latest advances in the field at ...

Exploring new ways to treat different cancers

This eBook is edited by Dr.Atta-ur-Rahman and Dr. M. Iqbal Choudhary, published on May 31, 2019. Bentham Science's premier Anti-cancer ...

Shimmer and ClearSky announce partnership to improve analysis of wearable sensor data for CNS diseases

Credit: Shimmer Research CAMBRIDGE, MA and YORK, ENGLAND - June 19, 2019 - Shimmer Research, a global leader in wearable ...

Drug boosts growth in youngsters with most common form of dwarfism, new study finds

June 18, 2019

Results of the four-year study are summarised online June 18 in the New England Journal of Medicine A groundbreaking drug ...

Colorado enrolls first patient in clinical trial of HDAC inhibitor, OKI-179

Credit: University of Colorado Cancer Center OnKure, Inc. and the University of Colorado Cancer Center today announced enrollment of the ...

Topical cream shows promise in treatment of skin pigmentation disease, vitiligo

Nearly 50% of patients in national clinical trial saw significant improvement in skin condition that affected Michael Jackson, impacts millions ...

Canada’s largest national dementia research initiative funded for second phase by the CIHR

Baycrest will become the scientific headquarters to the Canadian Consortium on Neurodegeneration in Aging, the premier research hub that brings ...

Harvard chemists’ breakthrough in synthesis advances a potent anti-cancer agent

'Unprecedented achievement' provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway It's a feat three ...

Identification of protective antibodies may be key to effective malaria vaccine

An Oxford-led study has identified the antibodies that may hold the key to creating the first effective vaccine against malaria ...

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer

NRG oncology trial reaffirms carboplatin and paclitaxel chemotherapy alone should remain standard treatment for endometrial cancer The New England Journal ...

Common conditions keep many patients out of knee cartilage research studies

Some of the most common traits among patients with cartilage issues in the knee are excluding them from participating in ...

Making it personal: How genetic technologies are changing the face of medicine

For the future of medicine, clinicians and scientists at Children's Hospital Los Angeles look to our genes The age of ...

PCSK9 inhibitors: Specific studies are mandatory to prove efficacy and safety in CKD

Chronic kidney disease (CKD) is associated with a substantially increased risk for the development of atherosclerotic cardiovascular disease (CVD). Accordingly, ...

Clinical trials and research priorities in dialysis patients: Time for a new approach?

Patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality, and there are virtually no therapeutic interventions besides ...

Phase 3 topline data for ULTOMIRIS® (ravulizumab) in aHUS presented at ERA-EDTA Congress